NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models
Ping Zhang,1 Julie Marill,1 Audrey Darmon,1 Naeemunnisa Mohamed Anesary,1 Bo Lu,2 Sébastien Paris1 1Nanobiotix, Paris, France; 2Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, 19107, USACorrespondence: Sébastien ParisNanobiotix, 60 rue de Wattig...
Main Authors: | Zhang P, Marill J, Darmon A, Mohamed Anesary N, Lu B, Paris S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/nbtxr3-radiotherapy-activated-functionalized-hafnium-oxide-nanoparticl-peer-reviewed-article-IJN |
Similar Items
-
Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire
by: Audrey Darmon, et al.
Published: (2022-06-01) -
Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization
by: Jordan Da Silva, et al.
Published: (2024-01-01) -
Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases
by: Daniel Thomas Ginat, et al.
Published: (2022-09-01) -
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
by: Yun Hu, et al.
Published: (2022-11-01) -
Radioenhancement with the Combination of Docetaxel and Ultrasound Microbubbles: In Vivo Prostate Cancer
by: Firas Almasri, et al.
Published: (2023-05-01)